Citigroup Inc Eyenovia, Inc. Transaction History

Citigroup Inc

$163 Billion
Q4 2024

A detailed history of Citigroup Inc transactions in Eyenovia, Inc. stock. As of the latest transaction made, Citigroup Inc holds 243,650 shares of EYEN stock, worth $458,062. This represents 0.0% of its overall portfolio holdings.

Number of Shares

243,650

Previous 407 59764.86%

Holding current value

$458,062

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$0.08 - $0.57 $19,459 - $138,648	243,243 Added 59764.86%	243,650 $36,000
Q3 2024 Nov 12, 2024	SELL	$0.46 - $1.44 $2,081 - $6,514	-4,524 Reduced 91.75%	407 $0
Q2 2024 Aug 12, 2024	SELL	$0.52 - $1.06 $207 - $422	-399 Reduced 7.49%	4,931 $2,000
Q1 2024 May 10, 2024	SELL	$0.99 - $2.37 $149 - $357	-151 Reduced 2.75%	5,330 $5,000
Q4 2023 Feb 09, 2024	BUY	$1.08 - $2.08 $5,823 - $11,215	5,392 Added 6058.43%	5,481 $11,000
Q3 2023 Nov 09, 2023	SELL	$1.57 - $2.54 $12,864 - $20,812	-8,194 Reduced 98.93%	89 $0
Q2 2023 Aug 10, 2023	BUY	$2.21 - $5.75 $18,305 - $47,627	8,283 New	8,283 $19,000

Others Institutions Holding EYEN

# of Institutions

Shares Held

5.68M

Call Options Held

72.9K

Put Options Held

36.3K

View Full List

About EYENOVIA, INC.

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $64.3M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

More about EYEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account